Retinoblastoma
Retinoblastoma is a malignant tumor of the eye that originates from the retina. It can affect one or both eyes in children, and is typically diagnosed in those 5 years old or younger.
This rare cancer of the eye is caused by a gene abnormality in chromosomes that contain genetic code that control cell growth and development. Most cases of retinoblastoma appear without warning or family precedent. Around 40 percent of children with retinoblastoma have an inherited form of the tumor, even if it has not presented in any other member of the family. Ten percent have a family member with the disease.
Retinoblastoma is detected using a CT scan and/or eye ultrasound. Other tests, such as an MRI or blood work, may be administered as well. An oncologist (doctor who specializes in cancer treatment) is often included in diagnosis and treatment.
Retinoblastoma is one of the most curable of childhood cancers, with 95 percent surviving. Prognosis depends on size and location of the tumor or tumors.
Treatment options include:
- Laser therapy: laser light is used to destroy the tumor.
- Cryotherapy: freezing treatment is used to destroy the tumor.
- Chemotherapy: drug treatment given via the bloodstream is used to kill the cancer cells; it is sometimes used in conjunction with laser therapy.
- Radiotherapy: high energy radiation is used to destroy cancer cells.
- Enucleation: removal of the eye.
Source: American Association for Pediatric Ophthalmology and Strabismus
Children’s Eye Care provides this information for general educational purposes only. It should not be construed as personal medical advice. Information published on this website is not intended to replace, supplant, or augment a consultation with an eye care professional. Children’s Eye Care disclaims any and all liability for injury or other damages that could result from use of the information obtained from this site.
SCHEDULE AN APPOINTMENT
RELATED POSTS
What’s new with pediatric glaucoma
John D. Baker, MD Pediatric Ophthalmology Symposium 2025 | Baker Day Detroit
The John D. Baker, MD Pediatric Ophthalmology Symposium (Baker Day) Date: Friday, May 16, 2025. Lecture: 8:00 – 9:30 am Case Presentations: 10:00 am – 4:00 pm Location: Children’s Hospital of Michigan, 3901 Beaubien Blvd, Detroit, MI For nearly four decades, the John D. Baker, MD Pediatric Ophthalmology Symposium, affectionately known as “Baker Day,” has brought together pediatric ophthalmologists, orthoptists,
Feb. 04, 2025
Viewing the Eclipse
Fake solar eclipse glasses are in the market. Make sure everyone you love knows how to be safe when watching the upcoming solar eclipse. Visit the American Astronomical Society’s website to learn more about the appropriate precautions to take when viewing the eclipse. https://eclipse.aas.org/eye-safety/iso-certification #SolarEclipseSafety #PediatricOphthalmology
Aug. 17, 2017
Nina Palomba completes CEC’s Orthoptic Program
We are proud to announce that our orthoptic student has successful completed our two year orthoptic training program. Nina Palomba, BS, COA has completed the intensive program as well as passed her written boards. This fall she will take her oral boards with the American Orthoptic Council to become a board-certified orthoptist. She will then join the Department of
Aug. 26, 2015
Stephen Burwell completes CEC’s Orthoptic Program
We are proud to announce that our orthoptic student has successful completed our two year orthoptic training program. Stephen Burwell, BS, COT has completed the intensive program as well as passed his written and oral boards with the American Orthoptic Council to become a board-certified orthoptist. He will then join Children’s Eye Care as a staff orthoptist. Congratulations to Stephen
Sep. 17, 2016
view all articles